Jasper Therapeutics is trading at $0.66, down 6.23%, as no clear company-specific announcement has emerged on September 3, 2026.
- The company’s investor-relations page lists its latest releases as August 14 and July 16, rather than a new September 3 catalyst.
- Broader markets and biotech are rising, making sector or macro weakness insufficient to explain the decline; the catalyst remains unclear.